Ann Kepler is a medical journalist based in Chicago.
Related Articles
T Cells in Systemic Lupus Erythematosus
Progress toward targeted therapy
Doest Rheumatoid Arthritis Take a Toll?
Exploring the Toll background
Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease
A perspective on B cell–targeted therapies in autoimmune disease
An Oral Targeted Therapy: RheumMadness 2022 Pim Kinases Scouting Report
According to research, Pim kinases contribute to the pathogenesis of rheumatoid arthritis (RA) and may have the therapeutic potential for inhibition in patients with RA.